{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:15:15Z","timestamp":1791357315289,"version":"4.3.1"},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1001\/amajethics.2019.332","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T15:00:49Z","timestamp":1556031649000},"page":"E332-336","source":"Crossref","is-referenced-by-count":5,"title":["Should Trackable Pill Technologies Be Used to Facilitate Adherence Among Patients Without Insight?"],"prefix":"10.1001","volume":"21","member":"10","published-online":{"date-parts":[[2019,4,1]]},"container-title":["AMA Journal of Ethics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journalofethics.ama-assn.org\/article\/should-trackable-pill-technologies-be-used-facilitate-adherence-among-patients-without-insight\/2019-04","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T15:55:42Z","timestamp":1683734142000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalofethics.ama-assn.org\/article\/should-trackable-pill-technologies-be-used-facilitate-adherence-among-patients-without-insight\/2019-04"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,1]]},"references-count":0,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4,1]]}},"alternative-id":["10.1001\/amajethics.2019.332"],"URL":"https:\/\/doi.org\/10.1001\/amajethics.2019.332","relation":{},"ISSN":["2376-6980"],"issn-type":[{"value":"2376-6980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,1]]}}}